CEDANDAR

Welcome to the Brand page for “CEDANDAR”, which is offered here for Orally administered pharmaceutical preparations available by prescription only, for the treatment of a rare protein misfolding disease, amyloidosis;.

Its status is currently believed to be active. Its class is unavailable. “CEDANDAR” is believed to be currently owned by “FoldRx Pharmaceuticals, Inc.”

Owner:
FOLDRX PHARMACEUTICALS, INC.
Owner Details
Description:
Orally administered pharmaceutical preparations available by prescription only, for the treatment of a rare protein misfolding disease, amyloidosis;
Categories: ORALLY ADMINISTERED PHARMACEUTICAL PREPARATIONS AVAILABLE